Surface Therapeutics - Acquired by Serentis Inc

Surface Therapeutics is a drug discovery and development company developing innovative new drugs to treat inflammatory epithelial diseases of the skin and lungs.

Surface Therapeutics was acquired by Serentis Inc in September 2007.